{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:20:00Z","timestamp":1784330400119,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN207121"],"award-info":[{"award-number":["IN207121"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Autonoma de Mexico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.arcmed.2023.102937","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T07:32:10Z","timestamp":1706772730000},"page":"102937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["CETP-derived Peptide Seq-1, the Key Component of HB-ATV-8 Vaccine Prevents Stress Responses, and Promotes Downregulation of Pro-Fibrotic Genes in Hepatocytes and Stellate Cells"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7385-5986","authenticated-orcid":false,"given":"Sandra","family":"Calixto-Tlacomulco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Luna-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-3302","authenticated-orcid":false,"given":"Blanca","family":"Delgado-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Guti\u00e9rrez-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Reyes-Grajeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8007-6993","authenticated-orcid":false,"given":"Jaime","family":"Mas-Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2023.102937_bib0001","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0002","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fphys.2012.00248","article-title":"Liver Fibrogenesis in Non-Alcoholic Steatohepatitis","volume":"3","author":"Bian","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0003","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis-new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0004","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2023.102937_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","article-title":"Fatty liver: A novel component of the metabolic syndrome","volume":"28","author":"Kotronen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0006","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease","volume":"363","author":"Targher","year":"2010","journal-title":"New Eng J Med"},{"key":"10.1016\/j.arcmed.2023.102937_bib0007","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/0929867326666190326113607","article-title":"Obesity and Body Composition in Man and Woman: Associated Diseases and the New Role of Gut Microbiota","volume":"27","author":"Avolio","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.arcmed.2023.102937_bib0008","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","article-title":"The metabolic syndrome","volume":"375","author":"Eckel","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.arcmed.2023.102937_bib0009","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2023.102937_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11883-022-01028-4","article-title":"Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease","volume":"24","author":"Martin","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.arcmed.2023.102937_bib0011","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.3390\/jcm11102838","article-title":"Association of Oxidized Low-Density Lipoprotein in Nonalcoholic Fatty Liver Disease with High-Risk Plaque on Coronary Computed Tomography Angiography: A Matched Case\u2013Control Study","volume":"11","author":"Nishihara","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.arcmed.2023.102937_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.arcmed.2023.102937_bib0013","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2023.102937_bib0014","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.3390\/ijms23158229","article-title":"Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis","volume":"23","author":"van den Hoek","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2023.102937_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11883-020-0820-8","article-title":"Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis","volume":"22","author":"Abdallah","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.arcmed.2023.102937_bib0016","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1042\/CS20200446","article-title":"Non-alcoholic fatty liver disease: A metabolic burden promoting atherosclerosis","volume":"134","author":"Zhang","year":"2020","journal-title":"Clin Sci"},{"key":"10.1016\/j.arcmed.2023.102937_bib0017","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.3390\/ijms20205037","article-title":"Development and progression of non-alcoholic fatty liver disease: The role of advanced glycation end products","volume":"20","author":"Fernando","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2023.102937_bib0018","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/biof.1018","article-title":"An update on advanced glycation endproducts and atherosclerosis","volume":"38","author":"Del Turco","year":"2012","journal-title":"BioFactors"},{"key":"10.1016\/j.arcmed.2023.102937_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2015.05.001","article-title":"Nitric oxide in liver diseases","volume":"1","author":"Iwakiri","year":"2015","journal-title":"Trends Pharm Sci"},{"key":"10.1016\/j.arcmed.2023.102937_bib0021","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2014.05.016","article-title":"Regulation of obesity and insulin resistance by nitric oxide","volume":"73","author":"Sansbury","year":"2014","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.arcmed.2023.102937_bib0022","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcmgh.2021.08.002","article-title":"E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8\/9","volume":"13","author":"Rodrigues","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0023","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J Physiol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0024","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.5858\/2007-131-1728-HSCALF","article-title":"Hepatic stellate cells and liver fibrosis","volume":"131","author":"Moreira","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.arcmed.2023.102937_bib0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nature Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0026","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic stellate cells as a target for the treatment of liver fibrosis","volume":"21","author":"Bataller","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.arcmed.2023.102937_bib0027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.arcmed.2023.102937_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2021.06.005","article-title":"Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication","volume":"33","author":"Loft","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.arcmed.2023.102937_bib0029","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in Hepatic Stellate Cell Activation and Liver Fibrogenesis\u2014Updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.arcmed.2023.102937_bib0030","unstructured":"Mas-Oliva J, Garc\u00eda-Gonz\u00e1lez V, Delgado-Coello BA, et al. Vacuna de aplicaci\u00f3n nasal contra el desarrollo de la enfermedad ateroscler\u00f3tica y el h\u00edgado graso. MX347400B (Patent) 2017."},{"key":"10.1016\/j.arcmed.2023.102937_bib0031","doi-asserted-by":"crossref","unstructured":"Mas-Oliva Jaime, Garc\u00eda-Gonz\u00e1lez VG, Delgado-Coello BA, et al. Nasal vaccine against the development of atherosclerosis disease and fatty liver. US9539312B2 (Patent) 2017.","DOI":"10.1016\/j.atherosclerosis.2016.07.020"},{"key":"10.1016\/j.arcmed.2023.102937_bib0032","unstructured":"Mas-Oliva J, Garc\u00eda-Gonz\u00e1lez VG, Delgado-Coello BA, et al. Nasal vaccine against the development of atherosclerosis disease and fatty liver. EP2868327A4 (Patent) 2021."},{"key":"10.1016\/j.arcmed.2023.102937_bib0033","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.arcmed.2015.06.004","article-title":"Reality of a Vaccine in the Prevention and Treatment of Atherosclerosis","volume":"46","author":"Garc\u00eda-Gonz\u00e1lez","year":"2015","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2023.102937_bib0034","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.arcmed.2019.01.007","article-title":"Therapeutic Intranasal Vaccine HB-ATV-8 Prevents Atherogenesis and Non-alcoholic Fatty Liver Disease in a Pig Model of Atherosclerosis","volume":"49","author":"Guti\u00e9rrez-Vidal","year":"2018","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2023.102937_bib0035","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.atherosclerosis.2017.06.177","article-title":"Preclinical evidence studying intranasal HB-ATV-8 vaccine in a porcine model of atherosclerosis shows high efficiency in the prevention of atherogenesis and fatty liver disease","volume":"263","author":"Mas-Oliva","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arcmed.2023.102937_bib0036","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1016\/j.atherosclerosis.2020.10.426","article-title":"Molecular events involved in the efficacy of therapeutic vaccine HB-ATV-8","volume":"315","author":"Mas-Oliva","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arcmed.2023.102937_bib0038","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2023.102937_bib0037","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsb.2014.02.002","article-title":"Key structural arrangements at the C-terminus domain of CETP suggest a potential mechanism for lipid-transfer activity","volume":"186","author":"Garc\u00eda-Gonz\u00e1lez","year":"2014","journal-title":"J Struct Biol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0039","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-4838(97)00156-8","article-title":"Stability of the C-terminal peptide of CETP mediated through an (i, i+4) array","volume":"1384","author":"Bola\u00f1os-Garc\u00eda","year":"1998","journal-title":"Biochim Biophys Acta - Prot Struct Mol Enzymol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0040","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0021-9258(18)53947-8","article-title":"Point Mutagenesis of Carboxyl-terminal Amino Acids of Cholesteryl Ester Transfer Protein opposite faces of an amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody","volume":"268","author":"Wang","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2023.102937_bib0041","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1074\/jbc.270.2.612","article-title":"Defective Binding of Neutral Lipids by a Carboxyl-terminal Deletion Mutant of Cholesteryl Ester Transfer Protein: evidence for a carboxyl-terminal cholesteryl ester binding site essential for neutral lipid transfer activity","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2023.102937_bib0042","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1073\/pnas.0903919106","article-title":"Infectious tolerance via the consumption of essential amino acids and mTOR signaling","volume":"106","author":"Cobbold","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2023.102937_bib0043","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2023.102937_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.661709","article-title":"Regulatory T Cell-Related Gene Biomarkers in the Deterioration of Atherosclerosis","volume":"8","author":"Xia","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.arcmed.2023.102937_bib0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/cr.2009.73","article-title":"Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells","volume":"19","author":"Wobser","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.arcmed.2023.102937_bib0046","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yexmp.2014.12.006","article-title":"The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation","volume":"98","author":"Giraudi","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0047","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016897118","article-title":"Nile Red fluorescence spectroscopy reports early physicochemical changes in myelin with high sensitivity","volume":"118","author":"Teo","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2023.102937_bib0048","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","article-title":"Neutral red uptake assay for the estimation of cell viability\/cytotoxicity","volume":"3","author":"Repetto","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.arcmed.2023.102937_bib0049","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2023.102937_bib0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: Integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J Clin Inv"},{"key":"10.1016\/j.arcmed.2023.102937_bib0051","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0052","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n - 6\/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"Araya","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.arcmed.2023.102937_bib0053","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1091980","article-title":"Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease","volume":"28","author":"Malhi","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.arcmed.2023.102937_bib0054","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2023.102937_bib0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome\u2013an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2023.102937_bib0056","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/138161210791208875","article-title":"Insulin Resistance in Nonalcoholic Fatty Liver Disease","volume":"16","author":"Bugianesi","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.arcmed.2023.102937_bib0057","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2023.102937_bib0058","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/ijms17122082","article-title":"Pathophysiology of Non Alcoholic Fatty Liver Disease","volume":"17","author":"Petta","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2023.102937_bib0059","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.tiv.2011.02.004","article-title":"Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte","volume":"25","author":"Wang","year":"2011","journal-title":"Tox in vitro"},{"issue":"Suppl.2","key":"10.1016\/j.arcmed.2023.102937_bib0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1746.2011.07003.x","article-title":"Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease","volume":"27","author":"Gao","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0061","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.24517","article-title":"Inflammation-associated interleukin-6\/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice","volume":"54","author":"Miller","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2023.102937_bib0062","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1471-4906(02)00009-1","article-title":"The dual role of IL-10","volume":"24","author":"Mocellin","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100477","article-title":"Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease","volume":"4","author":"McGlinchey","year":"2022","journal-title":"JHEP Reports"},{"key":"10.1016\/j.arcmed.2023.102937_bib0064","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of Liver Fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Ann Rev Path: Mechanisms of Disease"},{"key":"10.1016\/j.arcmed.2023.102937_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/egh.11.92","article-title":"Update on hepatic stellate cells: Pathogenic role in liver fibrosis and novel isolation techniques","volume":"6","author":"Tacke","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2023.102937_bib0066","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.arcmed.2023.102937_bib0067","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/labinvest.3700109","article-title":"Asbestos-derived reactive oxygen species activate TGF-beta1","volume":"84","author":"Pociask","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.arcmed.2023.102937_bib0068","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1667\/RR0695.1","article-title":"Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species","volume":"166","author":"Jobling","year":"2006","journal-title":"Radiat Res"},{"key":"10.1016\/j.arcmed.2023.102937_bib0069","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000374096","article-title":"Pathophysiology of Liver Fibrosis","volume":"33","author":"Pinzani","year":"2015","journal-title":"Digestive Dis"},{"key":"10.1016\/j.arcmed.2023.102937_bib0070","doi-asserted-by":"crossref","first-page":"d1720","DOI":"10.2741\/pinzani","article-title":"PDGF and signal transduction in hepatic stellate cells","volume":"7","author":"Pinzani","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.arcmed.2023.102937_bib0071","first-page":"361","article-title":"Molecular Pathogenesis of Liver Fibrosis","volume":"120","author":"Brenner","year":"2009","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.arcmed.2023.102937_bib0072","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J Gastroenterol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:53:04Z","timestamp":1759261984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440923001807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0188440923001807"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102937","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CETP-derived Peptide Seq-1, the Key Component of HB-ATV-8 Vaccine Prevents Stress Responses, and Promotes Downregulation of Pro-Fibrotic Genes in Hepatocytes and Stellate Cells","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of Instituto Mexicano del Seguro Social (IMSS).","name":"copyright","label":"Copyright"}],"article-number":"102937"}}